Table 1 Determination of the urinary tract functioning status and pretreatment eGFR of the 244 patients who underwent cisplatin-based chemotherapies
|  | Pretreatment eGFR ≥60 mL/min/1.73m2 | Pretreatment eGFR < 60 mL/min/1.73m2 | ||
|---|---|---|---|---|
Bilateral functioning kidneys (n = 83) | Solitary functioning kidney (n = 36) | Bilateral functioning kidneys (n = 45) | Solitary functioning kidney (n = 80) | |
Bilateral functoinal kidneys status | ||||
 BC with bilateral intact kidneys | 63 (75.9%) | – | 23 (51.2%) | – |
 BC with an unilateral nephrostomy | 4 (4.8%) | – | 9 (20.0%) | – |
 UTUC without nephroureterectomy or hydronephrosis | 11 (13.3%) | – | 11 (24.4%) | – |
 UTUC with an ipsilateral nephrostomy | 2 (2.4%) | – | 1 (2.2%) | – |
 BC + UTUC without nephroureterectomy or hydronephrosis | 3 (3.6%) | – | 1 (2.2%) | – |
Solitary functional kidney status | ||||
 UTUC after nephroureterectomy | – | 7 (19.4%) | – | 37 (46.4%) |
 UTUC without nephroureterectomy with an ipsilateral | – | 11 (30.5%) | – | 22 (27.5%) |
 UTUC in the solitary kidney without hydronephroisis | – | 1 (2.7%) | – | 2 (2.5%) |
 UTUC in the solitary kidney with the ipsilateral nephrostomy | – | 0 (0.0%) | – | 1 (1.2%) |
 BC with an unilateral hydroneohrosis | – | 7 (19.4%) | – | 5 (6.2%) |
 BC with bilateral hydronephroses with unilateral nephrostomy | – | 2 (5.6%) | – | 8 (10.0%) |
 BC with a solitary kidney | – | 3 (8.4%) | – | 1 (1.2%) |
 BC + UTUC after an unilateral nephroureterectomy | – | 3 (8.4%) | – | 2 (2.5%) |
 BC + UTUC with an unilateral hydronephrosis | – | 2 (5.6%) | – | 2 (2.5%) |